Learn more

GRIFOLS SA

Overview
  • Total Patents
    594
  • GoodIP Patent Rank
    10,314
  • Filing trend
    ⇩ 76.0%
About

GRIFOLS SA has a total of 594 patent applications. It decreased the IP activity by 76.0%. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), United States and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NAT JEWISH HEALTH, CHONGQING PEG BIO BIOTECHNOLOGY CO LTD and JAPAN HEALTH SCIENCE FOUND.

Patent filings per year

Chart showing GRIFOLS SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jorquera Nieto Juan Ignacio 61
#2 Ristol Debart Pere 59
#3 Hotta Joann 50
#4 Costa Rierola Montserrat 37
#5 Grifols Roura Victor 37
#6 Grancha Gamon Salvador 36
#7 Boira Bonhora Jordi 35
#8 Diez Cervantes Jose Maria 23
#9 Grifols Lucas Victor 23
#10 Roura Fernandez Carlos 22

Latest patents

Publication Filing date Title
EP3715632A1 Method for calibrating a peristaltic pump, method for dispensing a quantity of liquid by means of a peristaltic pump and device for producing sterile preparations that can execute said methods
BR102017007939A2 RFID LABEL FOR BOTH DISPOSAL OF BLOOD PRODUCTS, AND USE OF THE BLOOD
ES2602162A1 Container for a solution of human plasmatic proteins and the same preparation procedure
IL246769D0 Methods for purification of a virus produced in vitro and clearance assay for the virus
MX2016009048A Method for generating high-titer hepatitis e virus stocks and titration assay for hepatitis e virus.
ES2560110A1 Apparatus for automatic analysis of immunohematology on gel cards
ES2549694A1 ASEPTIC FILLING PROCEDURE OF A BAG
ES2524516A1 Preparation procedure of human albumin with reduced dissolved oxygen level
AU2013205138A1 Caprylate Viral Deactivation
ZA201302015B PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT
US2014134724A1 Culture medium for human mesenchymal stem cells
US2014026593A1 Thawing vessel for biological products
US2014031532A1 Purification of cell culture derived alpha1 protease inhibitor
AU2012340501A1 Compositions, methods, and kits for preparing sialylated recombinant proteins
AU2012324020A1 Method for purifying Factor VIII
MX2014002430A Identification of atypical antibodies in human blood and blood products.
CA2844878A1 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
RU2602913C2 Bag with blood product emptying device
KR20140060289A Rapid and accurate analysis of protein sialylation
ES2388223A1 Device for perfusion of a liver graft